WMT

125.75

-0.8%↓

COST

994.83

-0.33%↓

163.4

-1.1%↓

80.46

-0.31%↓

189.93

+1.84%↑

WMT

125.75

-0.8%↓

COST

994.83

-0.33%↓

163.4

-1.1%↓

80.46

-0.31%↓

189.93

+1.84%↑

WMT

125.75

-0.8%↓

COST

994.83

-0.33%↓

163.4

-1.1%↓

80.46

-0.31%↓

189.93

+1.84%↑

WMT

125.75

-0.8%↓

COST

994.83

-0.33%↓

163.4

-1.1%↓

80.46

-0.31%↓

189.93

+1.84%↑

WMT

125.75

-0.8%↓

COST

994.83

-0.33%↓

163.4

-1.1%↓

80.46

-0.31%↓

189.93

+1.84%↑

Home・Aktien・USANA Health Sciences Inc

USANA Health Sciences Inc

Geschlossen

21.12 -2.09

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

20.59

Max

21.57

Schlüsselkennzahlen
By Trading Economics
Einkommen	-17M -6.7M
Verkäufe	13M 226M
KGV Branchendurchschnitt	24.244 32.611
EPS	-0.15
Gewinnspanne	-3.118
Angestellte	1,700
EBITDA	16M 28M

Dividenden
By Dow Jones
Nächstes Ergebnis	21. Apr. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	17M 399M
Vorheriger Eröffnungskurs	23.21
Vorheriger Schlusskurs	21.12

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

28.405 / 29.84 Unterstützung & Widerstand

USANA Health Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Feb. 2026, 23:25 UTC

Heiße Aktien

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25. Feb. 2026, 23:15 UTC

Ergebnisse

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25. Feb. 2026, 23:54 UTC

Market Talk

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25. Feb. 2026, 23:47 UTC

Ergebnisse

Ferrovial 4Q Net EUR197M >FER.MC

25. Feb. 2026, 23:45 UTC

Ergebnisse

Ferrovial 4Q Rev EUR2.72B >FER.MC

25. Feb. 2026, 23:42 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25. Feb. 2026, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Company's Business Operations Remain Normal >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY EPS CNY47.67 >TCOM

25. Feb. 2026, 23:06 UTC

Ergebnisse

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25. Feb. 2026, 23:01 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25. Feb. 2026, 23:00 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

25. Feb. 2026, 23:00 UTC

Market Talk

Ergebnisse

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25. Feb. 2026, 22:56 UTC

Market Talk

Ergebnisse

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25. Feb. 2026, 22:43 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25. Feb. 2026, 22:40 UTC

Market Talk

Ergebnisse

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25. Feb. 2026, 22:40 UTC

Ergebnisse

Karoon Energy Says Search for New CFO Well Advanced

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says CFO Ray Church to Leave Company

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25. Feb. 2026, 22:38 UTC

Ergebnisse

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer-Vergleich

Kursveränderung

USANA Health Sciences Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für USANA Health Sciences Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

28.405 / 29.84Unterstützung & Widerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.